Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pain Pract. 2013 Nov;13(8):599-603. doi: 10.1111/papr.12049. Epub 2013 Mar 14.

Mast cells: a new target in the treatment of complex regional pain syndrome?

Author information

  • 1Center for Pain Medicine, Erasmus MC, Rotterdam, The Netherlands.

Abstract

There is convincing evidence that inflammation plays a pivotal role in the pathophysiology of complex regional pain syndrome (CRPS). Besides inflammation, central sensitization is also an important phenomenon. Mast cells are known to be involved in the inflammatory process of CRPS and also play a role (at least partially) in the process of central sensitization. In the development of a more mechanism-based treatment, influencing the activity of mast cells might be important in the treatment of CRPS. We describe the rationale for using medication that counteracts the effects of mast cells in the treatment of CRPS.

© 2013 The Authors Pain Practice © 2013 World Institute of Pain.

KEYWORDS:

complex regional pain syndromes; cytokines; mast cells; pathophysiology; treatment

PMID:
23489748
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Blackwell Publishing
    Loading ...
    Write to the Help Desk